Her2+ and b-HCG Producing Undifferentiated Gastric Adenocarcinoma

Her2+ and b-HCG Producing Undifferentiated Gastric Adenocarcinoma

A 25-year-old Hispanic female with a history of anemia, schizoaffective disorder, and psychosis was admitted for anemia associated with fatigue, weakness, shortness of breath, night sweats, weight loss, and abdominal and lower back pain for the past two months. On routine management, she was found to have a positive serum b-HCG of 80.4 (0-5 mIU/mL) but the patient denied any sexual activity in ...

Undifferentiated-type gastric adenocarcinoma: prognostic impact of three histological types

BACKGROUND The prognostic value of the three constituents of undifferentiated-type gastric adenocarcinoma remains unclear. The present study assessed the clinicopathological characteristics and prognosis of undifferentiated-type mucinous adenocarcinoma (uMAC) and signet ring cell carcinoma (SRC) compared with those of poorly differentiated adenocarcinoma (PDAC). METHODS In total, 1,376 patien...

HER2/neu Expression in Gastric and Esophagogastric Junction Adenocarcinoma

Background: Gastric cancer is one of the most commonly diagnosed cancer and one of the most common causes of cancerrelated deaths worldwide. HER-2/neu, a well-recognized factor, is indicated in the development of certain human solid tumors, notably breast cancer. High expression of HER2/neu has correlated with poor prognosis. Studies reveal combination of treatment with antibody targeting HER-2...

Cytoplasmic Expression of Her2 in Gastric Adenocarcinoma: an Unusual Finding

investigation of relationship between hepatitis b virus and gastric adenocarcinoma